ALMDT Median Technologies

EPA · FR · Healthcare · Medical Devices · mediantechnologies.com

3.255EUR-9.71%Mkt Cap: 172.04M $P/E: —3d ago

Median Technologies SA develops and markets software solutions and services for the use of medical images for the diagnosis and monitoring of patients with cancer in Europe, North America, and Asia. The company offers iC…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.60BUSDP/E 18.7

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

Key Statistics

Company

Market Cap172.04M USD

Enterprise Value136.41M USD

Revenue (TTM)25.51M USD

Gross Profit26.15M USD

Net Income (TTM)-37.03M USD

Revenue/Share0.64 EUR

Last Price3.255 EUR

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees199

CountryFR

SectorHealthcare

IndustryMedical Devices

ISINFR0011049824

Valuation

P/E (Trailing)—

P/E (Forward)-8.58

PEG—

EV/EBITDA-8.90

EV/Revenue5.35

P/S6.74

P/B-3.38

EPS (TTM)-0.93

EPS (Forward)-0.38

52W Range

2.72012% of range7.270

52W High7.270 EUR

52W Low2.720 EUR

Profitability

Gross Margin102.98%

Oper. Margin-57.75%

EBITDA Margin-60.09%

Profit Margin-145.85%

ROE96.92%

ROA-94.97%

Growth

Revenue Growth0.70%

Earnings Growth—

Cash Flow & Leverage

Operating CF-18.94M USD

CapEx (TTM)811.96K USD

FCF Margin35.44%

FCF Yield5.25%

Net Debt7.52M USD

Net Debt/EBITDA-0.49

Balance Sheet

Debt/Equity-0.62

Current Ratio0.67

Quick Ratio0.65

Book Value/Sh-0.96 EUR

Cash/Share0.50 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 EUR

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)11.97 EUR

Upside (mean)+267.6%

Target Range10.00 EUR – 14.00 EUR

10.00+267.6% to mean14.00

# Analysts3

Ownership

Shares Out.49.00M

Float29.37M

Insiders26.54%

Institutions11.50%

Technical

SMA 504.123 (-21.1%)

SMA 2004.620 (-29.6%)

Beta0.52

S&P 52W Chg14.58%

Avg Vol (30d)134.35K

Avg Vol (10d)132.01K

Technical Indicators

RSI (14)26.3

MACD-0.1766

MACD Signal-0.1439

MACD Hist.-0.0328

BB Upper4.212 EUR

BB Middle3.814 EUR

BB Lower3.417 EUR

BB Width20.85%

ATR (14)0.1845 EUR

Vol Ratio (20d)2.48x